278 related articles for article (PubMed ID: 28197812)
1. MCPIP1 contributes to clear cell renal cell carcinomas development.
Ligeza J; Marona P; Gach N; Lipert B; Miekus K; Wilk W; Jaszczynski J; Stelmach A; Loboda A; Dulak J; Branicki W; Rys J; Jura J
Angiogenesis; 2017 Aug; 20(3):325-340. PubMed ID: 28197812
[TBL] [Abstract][Full Text] [Related]
2. MCPIP1 Downregulation in Clear Cell Renal Cell Carcinoma Promotes Vascularization and Metastatic Progression.
Marona P; Górka J; Mazurek Z; Wilk W; Rys J; Majka M; Jura J; Miekus K
Cancer Res; 2017 Sep; 77(18):4905-4920. PubMed ID: 28716897
[TBL] [Abstract][Full Text] [Related]
3. The anti-inflammatory protein MCPIP1 inhibits the development of ccRCC by maintaining high levels of tumour suppressors.
Gorka J; Marona P; Kwapisz O; Rys J; Jura J; Miekus K
Eur J Pharmacol; 2020 Dec; 888():173591. PubMed ID: 32971087
[TBL] [Abstract][Full Text] [Related]
4. MCPIP1 regulates focal adhesion kinase and Rho GTPase-dependent migration in clear cell renal cell carcinoma.
Gorka J; Marona P; Kwapisz O; Rys J; Jura J; Miekus K
Eur J Pharmacol; 2022 May; 922():174804. PubMed ID: 35257717
[TBL] [Abstract][Full Text] [Related]
5. MCPIP1 contributes to the inflammatory response of UVB-treated keratinocytes.
Bugara B; Konieczny P; Wolnicka-Glubisz A; Eckhart L; Fischer H; Skalniak L; Borowczyk-Michalowska J; Drukala J; Jura J
J Dermatol Sci; 2017 Jul; 87(1):10-18. PubMed ID: 28377026
[TBL] [Abstract][Full Text] [Related]
6. Opposite prognostic roles of HIF1α and HIF2α expressions in bone metastatic clear cell renal cell cancer.
Szendrői A; Szász AM; Kardos M; Tőkés AM; Idan R; Szűcs M; Kulka J; Nyirády P; Szendrői M; Szállási Z; Győrffy B; Tímár J
Oncotarget; 2016 Jul; 7(27):42086-42098. PubMed ID: 27244898
[TBL] [Abstract][Full Text] [Related]
7. MCPIP1 contributes to the toxicity of proteasome inhibitor MG-132 in HeLa cells by the inhibition of NF-κB.
Skalniak L; Dziendziel M; Jura J
Mol Cell Biochem; 2014 Oct; 395(1-2):253-63. PubMed ID: 24992982
[TBL] [Abstract][Full Text] [Related]
8. Antidicer RNAse activity of monocyte chemotactic protein-induced protein-1 is critical for inducing angiogenesis.
Roy A; Zhang M; Saad Y; Kolattukudy PE
Am J Physiol Cell Physiol; 2013 Nov; 305(10):C1021-32. PubMed ID: 24048733
[TBL] [Abstract][Full Text] [Related]
9. MCPIP1 inhibits Wnt/β-catenin signaling pathway activity and modulates epithelial-mesenchymal transition during clear cell renal cell carcinoma progression by targeting miRNAs.
Gorka J; Marona P; Kwapisz O; Waligórska A; Pospiech E; Dobrucki JW; Rys J; Jura J; Miekus K
Oncogene; 2021 Dec; 40(50):6720-6735. PubMed ID: 34657130
[TBL] [Abstract][Full Text] [Related]
10. HIF2α-Dependent Lipid Storage Promotes Endoplasmic Reticulum Homeostasis in Clear-Cell Renal Cell Carcinoma.
Qiu B; Ackerman D; Sanchez DJ; Li B; Ochocki JD; Grazioli A; Bobrovnikova-Marjon E; Diehl JA; Keith B; Simon MC
Cancer Discov; 2015 Jun; 5(6):652-67. PubMed ID: 25829424
[TBL] [Abstract][Full Text] [Related]
11. Targeted inactivation of fh1 causes proliferative renal cyst development and activation of the hypoxia pathway.
Pollard PJ; Spencer-Dene B; Shukla D; Howarth K; Nye E; El-Bahrawy M; Deheragoda M; Joannou M; McDonald S; Martin A; Igarashi P; Varsani-Brown S; Rosewell I; Poulsom R; Maxwell P; Stamp GW; Tomlinson IP
Cancer Cell; 2007 Apr; 11(4):311-9. PubMed ID: 17418408
[TBL] [Abstract][Full Text] [Related]
12. Loss of VHL and hypoxia provokes PAX2 up-regulation in clear cell renal cell carcinoma.
Luu VD; Boysen G; Struckmann K; Casagrande S; von Teichman A; Wild PJ; Sulser T; Schraml P; Moch H
Clin Cancer Res; 2009 May; 15(10):3297-304. PubMed ID: 19401348
[TBL] [Abstract][Full Text] [Related]
13. Resistance to tyrosine kinase inhibitors promotes renal cancer progression through MCPIP1 tumor-suppressor downregulation and c-Met activation.
Marona P; Górka J; Kwapisz O; Jura J; Rys J; Hoffman RM; Miekus K
Cell Death Dis; 2022 Sep; 13(9):814. PubMed ID: 36138026
[TBL] [Abstract][Full Text] [Related]
14. MCPIP1 Exogenous Overexpression Inhibits Pathways Regulating MYCN Oncoprotein Stability in Neuroblastoma.
Boratyn E; Nowak I; Durbas M; Horwacik I; Sawicka A; Rokita H
J Cell Biochem; 2017 Jul; 118(7):1741-1755. PubMed ID: 27935099
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia.
Gunningham SP; Currie MJ; Han C; Turner K; Scott PA; Robinson BA; Harris AL; Fox SB
Cancer Res; 2001 Apr; 61(7):3206-11. PubMed ID: 11306510
[TBL] [Abstract][Full Text] [Related]
16. Monocyte Chemoattractant Protein-Induced Protein 1 Overexpression Modulates Transcriptome, Including MicroRNA, in Human Neuroblastoma Cells.
Boratyn E; Nowak I; Horwacik I; Durbas M; Mistarz A; Kukla M; Kaczówka P; Łastowska M; Jura J; Rokita H
J Cell Biochem; 2016 Mar; 117(3):694-707. PubMed ID: 26308737
[TBL] [Abstract][Full Text] [Related]
17. Mutant versions of von Hippel-Lindau (VHL) can protect HIF1α from SART1-mediated degradation in clear-cell renal cell carcinoma.
Ordóñez-Navadijo Á; Fuertes-Yebra E; Acosta-Iborra B; Balsa E; Elorza A; Aragonés J; Landazuri MO
Oncogene; 2016 Feb; 35(5):587-94. PubMed ID: 25915846
[TBL] [Abstract][Full Text] [Related]
18. A macrophage-dominant PI3K isoform controls hypoxia-induced HIF1α and HIF2α stability and tumor growth, angiogenesis, and metastasis.
Joshi S; Singh AR; Zulcic M; Durden DL
Mol Cancer Res; 2014 Oct; 12(10):1520-31. PubMed ID: 25103499
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
[TBL] [Abstract][Full Text] [Related]
20. Human renal carcinoma cells respond to Newcastle disease virus infection through activation of the p38 MAPK/NF-κB/IκBα pathway.
Ch'ng WC; Abd-Aziz N; Ong MH; Stanbridge EJ; Shafee N
Cell Oncol (Dordr); 2015 Aug; 38(4):279-88. PubMed ID: 25930675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
